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To determine if neuregulin 1 (NRG1) is associated with schizophrenia in Asian populations, we
investigated a Han Chinese population using both a family trio design and a case–control
design. A total of 25 microsatellite markers and single nucleotide polymorphisms (SNPs) were
genotyped spanning the 1.1 Mb NRG1 gene including markers of a seven-marker haplotype at
the 50end of the gene found to be in excess in Icelandic and Scottish schizophrenia patients.
The alleles of the individual markers forming the seven marker at-risk haplotype are not likely
to be causative as they are not in excess in patients in the Chinese population studied here.
However using unrelated patients, we find a novel haplotype (HAPChina 1), immediately
upstream of the Icelandic haplotype, in excess in patients (11.9% in patients vs 4.2% in
controls; P¼ 0.0000065, risk ratio (rr) 3.1), which was not significant when parental controls
were used. Another haplotype (HAPChina 2) overlapping the Icelandic risk haplotype was found
in excess in the Chinese (8.5% of patients vs 4.0% of unrelated controls; P¼ 0.003, rr 2.2) and
was also significant using parental controls only (P¼ 0.0047, rr 2.1). A four-marker haplotype at
the 30 end of the NRG1 gene, HAPChina 3, was found at a frequency of 23.8% in patients and
13.7% in nontransmitted parental haplotypes (P¼ 0.000042, rr¼ 2.0) but was not significant in
the case–control comparison. We conclude that different haplotypes within the boundaries of
the NRG1 gene may be associated with schizophrenia in the Han Chinese.
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Schizophrenia is a debilitating brain disease that
affects up to 1% of the population worldwide. There
is no cure, and treatments, which are mainly based on
antagonism of dopamine, serotonin and other neuro-
transmitter receptors in the brain, are only partially
effective. Although the aetiology of schizophrenia is
not well understood, there is longstanding evidence
of a genetic component, and recent twin studies place
the heritability of schizophrenia at more than 80%.1
Despite this high heritability, numerous candidate
gene association studies have failed to identify
susceptibility genes clearly. There are a variety of
reasons for this failure, including probable locus and
aetiological heterogeneity, characterised by the prob-
able existence of numerous genes of small effect, the
involvement of several biological pathways, lack of a
pathophysiology to help with the selection of candi-
date genes, and methodological difficulties related to
study design, statistical power and diagnostic validity
and reliability.2 Linkage analysis has been more
successful, with good evidence for genetic loci
identified on chromosomes 8p, 22q, 13q and several
other locations in the genome.3,4 These linkage
findings have led to systematic genetic mapping
efforts and positional candidate gene analysis of these
loci.5
In a recent publication by Stefansson et al,6 linkage
to chromosome 8p followed by haplotype mapping
with microsatellites and single nucleotide poly-
morphisms (SNPs) identified at-risk neuregulin 1
(NRG1) haplotypes for schizophrenia in patients from
Iceland. Three microsatellite at-risk haplotypes, each
individually in excess in patients, were found to have
the same SNP core haplotype upstream of the first 50
exon of NRG1. This finding has now been replicated
in two large case–control studies from Scotland7 and
the UK.8 The haplotype frequencies in Scottish and
Icelandic patients and in Scottish and Icelandic
controls, respectively, are very similar. A second
replication study in a UK population found a small
excess of the same NRG1 risk haplotype, particularly
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when patients with a family history were analysed,8
and analysis of a Han Chinese population using one
SNP from Stefansson et al,6 and two others selected at
random was also positive.9 Thus, evidence is accu-
mulating that NRG1 may be a genuine risk gene for
schizophrenia. However, association is restricted to
haplotypes, and the underlying functional variant(s)
that give rise to disease risk have not yet been
identified.
One means to approach the identification of risk
alleles is to examine diverse geographic groups to
search for common patterns of association. Under the
hypothesis that the NRG1-associated haplotype is a
surrogate marker for a susceptibility polymorphism
then, depending on the age and nature of the under-
lying risk alleles, a different associated haplotype
would be expected for different ethnic groups, even
though the risk allele(s) may be the same. If there are a
large number of variants with substantial allelic
heterogeneity at disease-causing loci, then there may
be many risk haplotypes each having weak associa-
tion with disease. Analysis of diverse ethnic groups
may help to answer these questions, not just through
simple replication but also through confirmation of
the region of the gene in which schizophrenia
susceptibility lies. In this study, we have investigated
a Han Chinese population using both a family trio
design and a case–control design, to determine if the
haplotype found in Iceland and Scotland is present in
the Chinese, and if not, whether alternative risk
haplotypes can be identified in the gene.
Materials and methods
Patient sample
Schizophrenia patients, their families and control
subjects were recruited from Sichuan Province, SW
China. The family trio design used 184 trios (parents
and one affected offspring) and 138 sibling pairs
(parents and at least two affected siblings). The case–
control design used 298 unrelated patients from the
families above and 336 normal Han Chinese controls.
All patients were interviewed by an experienced
psychiatrist using the SCID. Diagnosis was made
according to DSM-III-R or DSM-IV criteria (American
Psychiatric Association). Information was also col-
lected from examination of medical records and all
other available sources. Genomic DNA was extracted
from peripheral blood according to standard phenol–
chloroform methods. This study was approved by the
South London and Maudsley Trust ethical committee.
Informed consent was obtained from all patients and
control individuals and DNA samples were anon-
ymised.
Haplotype estimation
We estimated haplotype frequencies for unrelated
patients and unrelated controls. Two sets of control
haplotypes were created: one for unrelated controls
and the other for nontransmitted parental alleles for
patients. To handle missing genotypes and the lack of
familial information to derive the phase, our own
implementation of a likelihood approach, using the
expectation-maximization (EM) algorithm10 as a com-
putational tool, was applied to estimate the haplotype
frequencies. Under the null hypothesis, the affected
individuals and controls are assumed to have iden-
tical frequencies of all haplotypes. Under the alter-
native hypothesis, the candidate at-risk haplotype is
allowed to have a higher frequency in affected
individuals than controls, while the ratios of the
frequencies of all other haplotypes are assumed to be
the same in both groups. Likelihoods are maximized
separately under both hypotheses and corresponding
one-degree-of-freedom likelihood ratio statistics are
used to evaluate statistical significance. While our
own computer program was developed to fit our
chosen models, and to handle missing genotypes and
haplotypes with many markers efficiently, our use of
the EM-algorithm is very similar to methods used by
others.11–13 Although applied in a slightly different
setting, the one-degree-of-freedom model we use is
essentially that used by Clayton and Jones.14,15 The
method used here is identical to that used in
Stefansson et al.6
Genotyping
SNPs: SNP8NRG221533, SNP8NRG241930 and
SNP8NRG243177 were scored using a fluorescent-
based method.16 SNPNRG112232 is not significantly
polymorphic in the Chinese and is thus not included
in the analysis. The following microsatellite markers
spanning the NRG1 gene were genotyped as described
by Gretarsdottir et al:17 D8S1770, D8S1769, 29H12-1,
D8S1711, 29H12-121L21, 478B14-642, 478B14-848,
487-2, 420M9-1395, 420M9-1, D8S1810, 473C15-439,
72H22-1, 82H10-79B8, 244L21-8557, 225C17-4,
317J8-2123, 317J8-1, 317J8-2, 317J8-4858, S8S4792,
S8S1765. Amplimers can be found on deCODE
Genetics Web site and detailed sequence information
in GenBank (AF491780) and TPA (Third party
annotation) (BK000383).
LD mapping
In order to study the LD with microsatellites, an
extension to the definitions of D0 18 and its statistical
signicance for biallelic markers were utilized. The
extended D0 is averaged over all the possible allele
combinations of the two markers D0, weighted by the
marginal allele probabilities.19 The corresponding
P-value is defined as the minimum P-value for the
pair of markers over the same combinations, provided
the joint probability is higher than 0.05. Plotting for
all marker combinations, D0 in the upper-left corner
and the P-value in the lower-right corner suggest the
LD structure of the region (see Figure 2).
Results
Genotypes were successfully obtained for 25 poly-
morphisms: 22 microsatellites and three SNPs, across
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the NRG1 gene in family trios (184 affected schizo-
phrenic patients and their parents) and sibling pairs
(138 schizophrenic families with at least two affected
siblings and their parents). The positions of markers
genotyped in the exon 1 region of the sample are
shown in Figure 1.
Genotypes from 298 unrelated schizophrenia pa-
tients from the above families could be used in the
association analysis. Two sets of controls were used in
this study: a set of unrelated Han Chinese controls
(N¼336) and a set of nontransmitted parental
haplotypes (N¼552 chromosomes). We did a case–
control study first and then used the nontransmitted
parental haplotypes as control haplotypes, enabling
us to compare directly the frequency of the non-
transmitted haplotypes to their frequencies in the
case–control study.
Despite the fact that almost all of the individual
markers found in the extended Icelandic risk haplo-
types called HapA, HapB, HapC1 and HapC26 are
polymorphic in the Chinese population studied here,
we were not able to detect the extended haplotypes in
the Chinese population. However, the frequency of a
seven-marker at-risk haplotype, 290 kb, at the 50 end
of the NRG1 gene where the extended haplotypes
coincide (same alleles for the seven markers) was
estimated. As described in Stefansson et al,6 not all of
the seven markers have to be genotyped to identify
the haplotype due to linkage disequilibrium (LD)
within the 290 kb region. Five out of the seven
markers were genotyped and the frequency of the
seven-marker haplotype estimated 95 described in
Materials and methods. The P-values are two-sided,
without adjustment for multiple comparisons, and are
based on the EM algorithm. Single point P-values and
risk ratio (rr) are given in Table 1 for the five
genotyped markers of the seven-marker haplotype as
well as for the five-marker haplotype, a good surrogate
for the seven-marker haplotype. Neither the haplo-
type nor alleles for individual markers associating
with the haplotype were found in excess in this
Chinese population (Table 1).
Even though the seven-marker at-risk haplotype is
not in excess in the Chinese patients, other candidate
at-risk haplotypes may exist. We analysed the micro-
satellite haplotypes within the boundaries identified
by HapA, HapB and HapC, that is, including the first
50 exon of NRG1 and upstream sequence using both
unrelated controls haplotypes and nontransmitted
haplotypes from parents of patients. We searched for
haplotypes overlapping the NRG1 locus region using
the two different control groups and identified three
interesting haplotypes called HAPChina 1, HAPChina 2
and HAPChina 3. The P-values given are two-sided and
uncorrected for multiple testing.
Using unrelated patients we find a haplotype
(HAPChina 1), immediately upstream of the Icelandic
at-risk haplotype, in excess in patients (Figure 1). The
frequency of the HAPChina 1 is 11.9% in patients and
4.2% in controls (Table 2). This gives a P-value of
0.0000065 and a relative risk of 3.1. When we use the
nontransmitted parental haplotypes as controls, the
control frequency changes from 4.2 to 9.2% and the
uncorrected P-value increases from 0.0000065 to 0.12.
Figure 1 Marker and haplotype positions in the NRG1 gene. In the top panel, the 21 currently known exons for NRG1 are
shown together with the positions of the previously published Scottish/Icelandic haplotype (dark bar) and the three Chinese
haplotypes described in the current study (light bars). In the lower section, the exon 1 region containing HAPChina 1 and
HAPChina 2 is shown, together with the markers genotyped in the present study. SNPs are indicated by filled hexagons and
microsatellite markers by filled circles.
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Apart from chance differences, population stratifica-
tion is one likely explanation for this difference
between case–control and family-based analysis.
Another haplotype overlapping the seven-marker
at-risk haplotype found in Iceland is found in excess
in the Chinese population studied here. This haplo-
type (HAPChina 2; Figure 1) is found in 8.5% of patients
and 4.0% of sporadic controls. HAPChina 2 is in excess
whether the nontransmitted parental at-risk haplo-
types are used as controls or the population controls
are used (P¼ 0.003, rr 2.2 and P¼ 0.0047, rr 2.1,
respectively). The difference in frequency for HAP-
China 2 between patients and controls cannot, therefore,
be explained by population stratification since non-
transmitted haplotypes give similar results as the
unrelated controls.
When we look at other microsatellite haplotypes in
the large NRG1 gene downstream of the region
harbouring the at-risk haplotype, they show less
significant uncorrected P-values than haplotype HAP-
China 1 when unrelated controls are used. When
nontransmitted haplotypes are used, however, a
Table 1 Allele frequency for five markers from a seven-marker haplotype found in excess in schizophrenia patients in Iceland,
Scotland and UK
Percent frequency, significance and risk ratio (rr) for unrelated patients and controls
Markers Patients Control P rr
SNP8NRG221533 55.2 (285) 59.1 (250) 0.22 0.85
SNP8NRG241930 95.7 (290) 94.7 (259) 0.48 1.2
SNP8NRG243177 58.9 (292) 63.2 (256) 0.16 0.83
Three-marker SNP haplotypea 53.4 (292) 55.9 (267) 0.42 0.90
Five-marker haplotypeb 6.8 (292) 9.9 (276) 0.10 0.67
Estimates for three-marker and five-marker haplotypes are also given. The five-marker haplotype is a good surrogate
haplotype for the seven-marker haplotype.
aThe three-marker haplotype consists of SNP markers only. Marker order and names are as follows: SNP8NRG221533,
SNP8NRG241930, SNP8NRG243177. Alleles for the SNP haplotype are shown for individual SNPs in the table.
bThe five-marker haplotype consists of the following markers in this order: SNP8NRG221533, SNP8NRG241930,
SNP8NRG243177, 478B14-848 and 420M9-1395. Markers 478B14-848 and 420M9-1395 are microsatellite markers. The
other three markers are SNP markers. For patients, the number of genotyped individuals is given within parentheses. Control
frequency is here estimated from nontransmitted parental haplotypes and the number in parentheses refers to the number of
patients for whom nontransmitted parental haplotypes could be estimated.
Table 2 Frequency, significance and rr of the microsatellite haplotypes associated with schizophrenia in the Han Chinese
population
Frequency (%) and risk for unrelated patients
and unrelated controls
Frequency (%) and risk for unrelated patients and
nontransmitted parental alleles as controls
Markers Allele Patients Control P rr Patients Control P rr
HAPChina 1 11.9(231) 4.2(271) 0.0000065 3.1 11.7 9.2(205) 0.12 1.3
29H12-1 6 14.6(267) 8.3(307) 0.00038 1.9 14.6 13.2(231) 0.26 1.1
D8S1711 2 46.8(263) 42.9(297) 0.10 1.2 46.8 42.5(221) 0.10 1.2
HAPChina 2 8.5(298) 4.0(336) 0.0030 2.2 7.6 3.8(269) 0.0047 2.1
478B14-642 4 33.4(292) 28.6(325) 0.035 1.3 33.2 27.8(253) 0.025 1.3
487-2 20 65.8(279) 65.1(311) 0.41 1.0 65.9 63.4(240) 0.020 1.1
420M9-1395 2 67.9(238) 66.8(312) 0.36 1.0 65.9 63.4(240) 0.020 1.1
D8S1810 16 58.0(257) 54.7(296) 0.14 1.1 58.2 52.2(198) 0.037 1.3
HAPChina 3 26.9(297) 25.3(333) 0.29 1.1 23.8 13.7(269) 0.000042 2.0
317J8-2123 4 77.6(277) 78.0(318) 0.44 1.0 77.9 72.6(232) 0.025 1.3
317J8-1 0 62.3(280) 64.5(306) 0.22 0.91 62.5 62.5(234) 0.50 1.0
317J8-2 2 65.4(279) 65.8(301) 0.45 1.0 65.4 61.7(240) 0.11 1.2
317J8-4858 0 58.5(266) 52.9(323) 0.03 1.3 58.5 48.5(242) 0.00095 1.5
Parentheses show the number of patients with each haplotype. Both case–control and family-based analyses are shown.
HapChina 1 was chosen from the case–control study as the most significant haplotype associating with the disease. HapChina 3
was the most significant haplotype when nontransmitted parental haplotypes were used as control haplotypes. HapChina 2 is
found in excess both when controls from the case–control study were used and when nontransmitted parental alleles were
used as controls.
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four-marker haplotype, HAPChina 3 was found in
23.8% frequency in patients and 13.7% in nontrans-
mitted parental haplotypes (P¼0.000042, rr¼2.0).
Most of the NRG1 exons are located within this
haplotype at the 30 end of the gene (Figure 1). The
extent of LD across the region is illustrated in Figure
2. The five markers in the HAPChina 2 haplotype all
show significant LD with each other, with the
strongest LD relationships between the three micro-
satellites: D8S1810, 487-2 and 420M9-1395. LD
between the 50 marker 478B14-642 and this group of
three microsatellites was much lower (D0o0.2)
although still significant. Note the existence of a
haplotype block at the 50 end of the NRG1 gene, which
is flanked by HAPChina 1 and HAPChina 2 (Figure 2).
Discussion
The NRG1 gene was originally identified as a
susceptibility gene for schizophrenia by using a
combination of linkage and association approaches,
which identified a seven-marker risk haplotype
consisting of five SNPs and two microsatellites.6
This haplotype was also found in excess in schizo-
phrenia patients in Scotland7 and the UK8 popula-
tions sharing recent ancestry with the Norse and
Gaelic-derived Icelandic population, and a different
haplotype in a Han Chinese population.9 In the
present study, we genotyped five of the seven markers
from the at-risk haplotype and estimated the fre-
quency of the five-marker haplotype, a good surrogate
for the seven-marker haplotype. The five-marker
haplotype (surrogate for the seven-marker haplotype)
is not associating with schizophrenia. In fact, the
frequency is higher in the control group (Table 1).
Unlike the Han Chinese sample, we did not see an
excess of the SNP SNP8NRG221533 in our case–
control analysis and the allele is not transmitted more
often than expected to patients. The reason as to why
the association is found to the SNP8NRG221533 allele
in Yang et al9 study but not in our study is not clear,
and will require further analysis in other samples
from China.
The over-riding extended haplotypes, HapA, HapB,
HapC1 and HapC2 could not be identified in the
Chinese population described here probably as they
are spanning several LD blocks. Instead we have
identified three different potentially associated
Figure 2 LD relationships between microsatellite markers in the NRG1 gene in the Chinese population under study. Two
measures of LD are shown: D0 values on the upper-left side of the plot and P-values on the lower-right side. Scales for the LD
strength are provided for both measures to the right. Note the existence of a haplotype block at the 50 end of the NRG1 gene,
which is flanked by HAPChina 1 and HAPChina 2. The relative positions of the Chinese associated haplotypes and the Icelandic/
Scottish haplotypes are illustrated above the figure. The strongest block of LD in HAPChina 2 was between the three
microsatellites D8S1810, 487-2 and 420M9-1395 (D040.9).
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haplotypes, which we call HAPChina 1, HAPChina 2 and
HAPChina 3. The first two of these are at the 5
0 end of
the gene and the third spans most of the NRG1 exons
at the 30 end of the gene. The HAPChina 1 was
associated with schizophrenia in the case–control
analysis but not the family-based analysis, indicating
the possibility of population stratification in the
controls, whereas HAPChina 3 was in excess in patients
only in the family-based analysis. However, HAPChina
2 was in excess in patients in both analysis, and
furthermore is in the same position as the Icelandic/
Scottish risk haplotype, albeit with a different set of
markers and alleles. The family-based approach may
be a conservative one, whereas the use of unrelated
controls as the comparison group is sensitive to
population stratification, which may lead to false-
positive association.
Our failure to identify the same Icelandic/Scottish
schizophrenia risk haplotype in the Chinese is
perhaps unsurprising since Northern European and
Chinese population are separated by tens of thou-
sands of years, and a different relationship between
risk haplotypes and underlying pathogenic variants
may have evolved during this time. It is possible that
the same as-yet-unidentified disease-causing genetic
variant(s) exist in both the Chinese and European
populations but are associated with different over-
lying haplotypes. It is also possible that there is locus
heterogeneity at the NRG locus, with several risk
alleles that differ in occurrence and frequency
between geographic populations, or even multiple
rare alleles associated with various haplotypes that
will hamper attempts at replication.
The causative mutation in NRG has not yet been
identified since no individual polymorphisms show
strength of association comparable to haplotypes. The
apparent absence of changes in the amino-acid
structure of the genes6 implies a noncoding poly-
morphism with regulatory effects, which could lie
anywhere in a considerable region within or sur-
rounding the gene. Most causative alleles will lie on
associated haplotypes because of the simplified
haplotype block structure of much of the genome.20
Consequently, it will be difficult to distinguish
between a causative polymorphism and association
through LD by genetic methods alone. In addition, the
extent of conservation of haplotypes and their block
structure across ethnic groups is not clear, since
factors such as genetic drift, selection, mutation,
nonrandom mating combined with the dependence
of haplotypes on allele frequency could have pro-
found effects on haplotype structures.20 The analysis
of different ethnic groups, combined with hierarchi-
cal modelling of LD21 may be the most useful
approach to the identification of the underlying
pathogenic alleles.
Analysis of haplotypes across an extended region of
the genome such as the NRG locus involves the
analysis of many combinations of markers, and even
though the actual number of haplotypes seen is fewer
than the number theoretically possible, the statistical
effect of performing multiple tests combined with
phase uncertainty is a problem.14,15 However, fre-
quencies for 2–5-marker haplotypes were estimated
from the 25 genotyped markers spanning several LD
blocks and multiple testing has not been accounted
for. Although the analysis of families helps with
phase estimation, none of the microsatellite haplo-
types described here are significantly associated with
the disease after correcting for multiple testing.
Furthermore, difference in haplotype frequency be-
tween nontransmitted parental haplotypes and popu-
lation controls is of concern and stratification
between our patients and controls can therefore not
be excluded. However, we have identified three
haplotypes showing the strongest association in this
cohort and other research groups using Asian popula-
tions can test these. If relative risk for an at-risk
haplotype is as low as 2.0–2.5, the association is
difficult to detect unambiguously without direct
replication in another cohort.
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